Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.
- Published In:
- Diabetes & metabolic syndrome, 18(9), 103116 (2024)
- Authors:
- Nassar, Mahmoud, Nassar, Omar, Abosheaishaa, Hazem(2), Misra, Anoop
- Database ID:
- RPEP-08935
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08935APA
Nassar, Mahmoud; Nassar, Omar; Abosheaishaa, Hazem; Misra, Anoop. (2024). Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.. Diabetes & metabolic syndrome, 18(9), 103116. https://doi.org/10.1016/j.dsx.2024.103116
MLA
Nassar, Mahmoud, et al. "Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: A propensity matched global federated TriNetX database-based retrospective cohort study.." Diabetes & metabolic syndrome, 2024. https://doi.org/10.1016/j.dsx.2024.103116
RethinkPeptides
RethinkPeptides Research Database. "Decreased risk of recurrent acute pancreatitis with semaglut..." RPEP-08935. Retrieved from https://rethinkpeptides.com/research/nassar-2024-decreased-risk-of-recurrent
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.